The healthcare sector has been performing well, rising 15% this year, and is viewed as a stable investment during uncertain times. CVS Health Corp stands out among its peers, with analysts noting a favorable risk/reward profile. The stock is currently trading between $82 and $86, which is seen as a critical support level.
If CVS remains above this range, it is recommended to maintain long positions; if it falls below, investors should reassess their strategy. Key indicators suggest a potential upward momentum, with targets set at $99, which would close the gap from its last earnings report, and further upside to $105.
Over a longer timeframe, a breakout above $110 could lead to targets as high as $150 within six to nine months, supported by a new long-term uptrend and positive momentum signals. Jay Woods, Chief Market Strategist at Freedom Capital Markets, emphasizes the importance of managing risk around the $82 to $86 range while considering these bullish projections